S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)
S&P 500   4,957.13 (-1.08%)
DOW   37,869.42 (+0.25%)
QQQ   415.59 (-1.85%)
AAPL   165.04 (-1.20%)
MSFT   399.88 (-1.09%)
META   482.06 (-3.93%)
GOOGL   153.91 (-1.35%)
AMZN   174.56 (-2.60%)
TSLA   147.73 (-1.47%)
NVDA   782.23 (-7.62%)
AMD   147.03 (-5.19%)
NIO   3.82 (-4.50%)
BABA   68.94 (+0.09%)
T   16.48 (+0.92%)
F   12.09 (+0.25%)
MU   106.86 (-4.53%)
GE   148.58 (-2.85%)
CGC   8.06 (+2.94%)
DIS   112.30 (-0.12%)
AMC   3.19 (+9.25%)
PFE   25.90 (+2.01%)
PYPL   62.02 (-0.13%)
XOM   119.91 (+1.17%)
OTCMKTS:OCPNY

Olympus (OCPNY) Stock Price, News & Analysis

$18.00
-0.25 (-1.37%)
(As of 01/31/2023)
Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$16.80
$74.99
Volume
400 shs
Average Volume
860,265 shs
Market Capitalization
$23.15 billion
P/E Ratio
21.95
Dividend Yield
0.44%
Price Target
N/A
OCPNY stock logo

About Olympus Stock (OTCMKTS:OCPNY)

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

OCPNY Stock Price History

OCPNY Stock News Headlines

Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Olympus Announces Leadership Succession Plan
Here's what to expect from Olympus's earnings
Olympus Corp. (OCPNY) Upgraded to Buy: Here's Why
Olympus Launches Venture Capital Fund To Strengthen Medtech Leadership
What Wall Street expects from OLYMPUS's earnings
Thai Credit Retail Bank Weighing Bangkok IPO Next Year
Here's what Wall Street expects from Olympus's earnings
See More Headlines
Receive OCPNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/05/2021
Today
4/19/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Structural clay products
Sub-Industry
N/A
Current Symbol
OTCMKTS:OCPNY
CIK
N/A
Employees
31,557
Year Founded
1919

Profitability

Net Income
$1.03 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.74 billion
Cash Flow
$1.22 per share
Book Value
$3.50 per share

Miscellaneous

Outstanding Shares
1,285,890,000
Free Float
N/A
Market Cap
$23.15 billion
Optionable
Not Optionable
Beta
0.70

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Yasuo Takeuchi
    President, Chief Executive Officer & Director
  • Nacho Abia
    Chief Operating Officer
  • Chikashi Takeda
    Chief Financial Officer
  • André Roggan
    Executive Officer & Chief Technology Officer
  • Stephen Mark Kneebone
    Chief Information Officer & Executive Officer

Should I Buy Olympus Stock? OCPNY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Olympus Co.:

  • Olympus Co. has a diversified business model with segments in medical, scientific solutions, imaging, and others, providing stability and potential growth opportunities.
  • The company's focus on precision machineries and instruments, including endoscopy tools and microscopes, caters to essential industries with steady demand.
  • Olympus M.Zuiko Digital ED 14-150mm f/4-5.6 Lens has received positive reviews, indicating the company's commitment to innovation and quality products.
  • Recent developments in the biomaterial manufacturing and sales business showcase Olympus Co.'s adaptability to emerging markets and technologies.
  • The current stock price of Olympus Co. reflects a favorable valuation compared to industry peers, presenting a potential investment opportunity.

Cons

Investors should be bearish about investing in Olympus Co. for these reasons:

  • Olympus Co. operates in the structural clay products industry, which may be susceptible to economic downturns and fluctuations in construction activities.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Olympus pros and cons to contact@marketbeat.com.

OCPNY Stock Analysis - Frequently Asked Questions

How have OCPNY shares performed in 2024?

Olympus' stock was trading at $18.00 at the start of the year. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00.
View the best growth stocks for 2024 here
.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) announced its quarterly earnings data on Thursday, August, 5th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.03. The company earned $1.75 billion during the quarter, compared to analyst estimates of $1.49 billion. Olympus had a trailing twelve-month return on equity of 24.30% and a net margin of 13.80%.

Is Olympus a good dividend stock?

Olympus (OTCMKTS:OCPNY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.43%. The dividend payout ratio is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, OCPNY will have a dividend payout ratio of 9.20% next year. This indicates that the company will be able to sustain or increase its dividend.

How do I buy shares of Olympus?

Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Olympus have any subsidiaries?
The following companies are subsidiares of Olympus: AIZU OLYMPUS CORPORATION, ALGRAM GROUP LIMITED, AOMORI OLYMPUS CO. LTD., ARC MEDICAL DESIGN LIMITED, Advalytix AG, Arc Medical Design Limited, EVIDENT CORPORATION, EVIDENT NAGANO K.K., EVIDENT SCIENTIFIC SINGAPORE PTE. LTD., Evident Europe GmbH, Evident Europe GmbH - odštepný závod, Evident Europe GmbH Közvetlen Kereskedelmi Képviselete, Evident Europe GmbH Suomen sivuliike, Evident Korea Co. Ltd., Evident Scientific S. de R.L. de C.V., Evident Service Center Europe s.r.o., Evident Technology Center Europe GmbH, FH ORTHO, FH ORTHO SAS, FOURNITURES HOSPITALIERES INDUSTRIE, GYRUS MEDICAL LIMITED, Gyrus Acmi L.P., Gyrus Acmi LLC, Gyrus Ent L.L.C., Image Stream Medical Inc, Innov-X Systems Inc., KEYMED (IRELAND) LIMITED, KEYMED (MEDICAL & INDUSTRIAL EQUIPMENT) LIMITED, NAGANO OLYMPUS CO. LTD., OLIMPAS MOSKVA OOO, OLYMPUS (MALAYSIA) SDN. BHD., OLYMPUS (THAILAND) COMPANY LIMITED, OLYMPUS BUSINESS SERVICES SP Z O O, OLYMPUS DIGITAL SYSTEM DESIGN CORP., OLYMPUS ESTONIA OU, OLYMPUS EUROPA HOLDING SE, OLYMPUS GLOBAL TREASURY SERVICES LIMITED, OLYMPUS IBERIA SA., OLYMPUS IMAGING SINGAPORE PTE. LTD., OLYMPUS KEYMED GROUP LIMITED, OLYMPUS KEYMED INTERNATIONAL LIMITED, OLYMPUS MARKETING INC., OLYMPUS MEDICAL SYSTEMS CORP., OLYMPUS MEDICAL SYSTEMS VIETNAM CO. LTD, OLYMPUS OPTICAL TECHNOLOGY PHILIPPINES INC., OLYMPUS POLSKA SP Z O O, OLYMPUS SINGAPORE PTE. LTD., OLYMPUS SUPPORT MATE K.K., OLYMPUS TAIWAN CO. LTD., OLYMPUS TECHNOLOGIES SINGAPORE PTE LTD, OLYMPUS TERUMO BIOMATERIALS CORP., OLYMPUS VIET NAM COMPANY LIMITED, OLYMPUS Winter & Ibe GmbH, Olympus America Inc., Olympus América de México S.A. de C.V., Olympus Australia Pty Ltd, Olympus Austria Gesellschaft m.b.H., Olympus Belgium, Olympus Biotech Corporation, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group, Olympus Czech Group Podruznica Ljubljana, Olympus Czech Group s.r.o. Magyarországi Közvetlen Kereskedelmi Képviselete, Olympus Czech Group s.r.o. clen koncernu, Olympus Czech Group s.r.o. clen koncernu organizacná zložka, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Europa Management SE, Olympus Europa Property Management GmbH, Olympus Europa SE & Co. KG, Olympus Finland OY, Olympus France, Olympus Hong Kong and China Limited, Olympus Imaging de México S.A. de C.V., Olympus Italia SRL, Olympus Korea Co. Ltd., Olympus Latin America Inc., Olympus Medical Equipment Services America Inc., Olympus Medical Products Czech spol. s r.o., Olympus Medical Systems India Private Limited, Olympus NDT Canada Inc., Olympus Nederland B.V., Olympus New Zealand Limited, Olympus Norge AS, Olympus Optical do Brasil Ltda, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc., Olympus Surgical & Industrial America Inc., Olympus Surgical Technologies America Inc, Olympus Sverige AB, Olympus Winter & Ibe Properties GmbH & Co. KG, Olympus doo Beograd, Om Digital Solutions Americas Inc, Quest Innovations B.V., Quest Medical Imaging B.V., Quest Photonic Devices B.V., SHIRAKAWA OLYMPUS CO. LTD., Spirus Medical Inc., TMEDIX CORPORATION., and Veran Medical Technologies Inc..
Read More
This page (OTCMKTS:OCPNY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners